Key Insights

Highlights

Success Rate

80% trial completion

Published Results

22 trials with published results (21%)

Research Maturity

56 completed trials (54% of total)

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

13.5%

14 terminated out of 104 trials

Success Rate

80.0%

-6.5% vs benchmark

Late-Stage Pipeline

24%

25 trials in Phase 3/4

Results Transparency

39%

22 of 56 completed with results

Key Signals

22 with results80% success14 terminated

Data Visualizations

Phase Distribution

92Total
Not Applicable (44)
Early P 1 (2)
P 1 (12)
P 2 (9)
P 3 (11)
P 4 (14)

Trial Status

Completed56
Unknown23
Terminated14
Withdrawn6
Not Yet Recruiting2
Active Not Recruiting2

Trial Success Rate

80.0%

Benchmark: 86.5%

Based on 56 completed trials

Clinical Trials (104)

Showing 20 of 20 trials
NCT07432581Not ApplicableCompleted

Topical Insulin Dressing on Management of Diabetic Foot Ulcers

NCT01154374Phase 2CompletedPrimary

A Clinical Study of the Safety and Efficacy of MEBO® Wound Ointment in Subjects With Diabetic Foot Ulcers (Pilot)

NCT01070433Phase 2CompletedPrimary

A Clinical Study of the Safety and Efficacy of MEBO Wound Ointment in Subjects With Diabetic Foot Ulcers

NCT07193992Not Yet RecruitingPrimary

Assessment of Non Vascular Risk Factors for Severity of Diabetic Foot Ulcers (DFUs)

NCT02577120Phase 1Active Not Recruiting

Wound Healing Endpoint and Recurrence

NCT06189638Phase 2Active Not RecruitingPrimary

Phase II Study to Evaluate Efficacy and Safety of AMP Peptide PL-5 in Mild Infections of Diabetic Foot Ulcers

NCT06873646Early Phase 1Not Yet RecruitingPrimary

Wound Dressing Patch with Kelulut Honey-Infused Alginate (Tri-Gnate Alginate) for Effective Wound Care Management

NCT06693180RecruitingPrimary

Registry HBOT in DFU

NCT00432965Not ApplicableCompletedPrimary

Randomized, Controlled Multicenter Trial of Vacuum Assisted Closure Therapy™ in Diabetic Foot Ulcers

NCT00605189Not ApplicableTerminatedPrimary

A Trial Examining Cellular Energetics Related to Various Wound Treatment Therapies

NCT00847730Not ApplicableCompletedPrimary

Evaluating the Ease of Use of a VAC GranuFoam Bridge Dressing on Diabetic Foot Ulcers Receiving VAC Negative Pressure Wound Therapy

NCT05417425Phase 1CompletedPrimary

Omeza Products in Combination With Standard of Care for the Treatment of Diabetic Foot Ulcers

NCT02313428Not ApplicableTerminatedPrimary

Topical Oxygen Therapy for Diabetic Wounds

NCT05850611Early Phase 1UnknownPrimary

The Effect of Combination Therapy of Oral MB and PRP-FG in Patients With Non-healing Diabetic Foot Ulcer

NCT02463487Not ApplicableCompletedPrimary

Negative Pressure Wound Therapy as a Drug Delivery System

NCT02463500CompletedPrimary

UT Southwestern Diabetic Foot Ulcers (DFU) and Osteomyelitis (DFO) Recruitment Database, Data and Tissue Repository

NCT02055755WithdrawnPrimary

WEMR With Clinical Decision Support for Diabetic Foot Ulcers

NCT01454401Not ApplicableCompletedPrimary

LeucoPatch™ Study A Multicenter Study on the Effect of LeucoPatch™ in Diabetic Foot Ulcers

NCT05747872Not ApplicableCompletedPrimary

Effectiveness of Buerger Allen Exercise Among Type 2 Diabetes Mellitus Patients With Foot Ulcer

NCT02367690Phase 1WithdrawnPrimary

Study of Safety, Tolerability, and Pharmacokinetics of Topical Selinexor (KPT-330) Diabetic Foot Ulcer (DFU) Patients

Scroll to load more

Research Network

Activity Timeline